|
HS Code |
487681 |
| Product Name | Fexofenadine Hydrochloride Reference Standard |
| Cas Number | 153439-40-8 |
| Molecular Formula | C32H39NO4·HCl |
| Molecular Weight | 538.12 g/mol |
| Purity | Typically ≥98% |
| Appearance | White to off-white powder |
| Storage Temperature | 2-8°C |
| Catalog Number Sigma | F4677 |
| Catalog Number Merck | F4677 |
| Catalog Number Tcl | F0117 |
| Melting Point | 190-194°C |
| Solubility | Slightly soluble in water, DMSO |
| Usage | Pharmaceutical reference standard |
| Synonyms | Fexofenadine HCl |
| Inchi Key | IKDKKBKDIJQEJF-FWZJPZCASA-N |
As an accredited Fexofenadine Hydrochloride Reference Standard factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a sealed amber glass vial containing 100 mg of Fexofenadine Hydrochloride Reference Standard, labeled by Sigma Aldrich. |
| Shipping | Fexofenadine Hydrochloride Reference Standard is shipped by Sigma Aldrich/Merck/TCI Chemical in compliance with regulatory guidelines for chemical standards. The product is securely packaged in labeled containers, protected from moisture and light. Shipping typically uses temperature-controlled methods if required, with accompanying safety data sheets and documentation for traceability and safe handling. |
| Storage | Fexofenadine Hydrochloride Reference Standard should be stored in a tightly closed container at 2-8°C (refrigerated), protected from light, moisture, and excessive heat. Store in a dry, well-ventilated area, away from incompatible substances. Ensure labeling and handling comply with safety guidelines as provided by Sigma Aldrich, Merck, or TCI Chemical documentation for reference standards. |
Competitive Fexofenadine Hydrochloride Reference Standard prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer with deep roots in supplying reference standards for pharmaceutical analysis, we know the everyday challenges quality control teams face. Producing a reference standard like Fexofenadine Hydrochloride isn’t only about matching a theoretical purity number. It means building reliable, reproducible material lots that help analysts anchor their instrumentation and procedures, day after day, across batches and regulatory submissions. Our standard meets recognized purity benchmarks for chemical reference substances, and every lot undergoes deliberate, meticulous processes anchored in decades of analytical routine.
For every batch of Fexofenadine Hydrochloride reference material we manufacture, we start directly from well-characterized, controlled raw materials. This isn’t left to chance. Our in-house team synthesizes the compound under prescribed conditions, drawing on the same synthesis routes used in pharmaceutical manufacturing. By managing process steps from raw input to the final isolated compound, we gain confidence not just in measured purity, but also in the absence of synthetic by-products and residual solvents. Every decision — crystallization, purification, drying — follows methods already well-established by synthetic chemists and process developers who understand the possible points of contamination in detail.
Purity assessment goes well beyond a single HPLC or UPLC trace. As manufacturers, we use orthogonal analysis techniques, including NMR, FT-IR, and LC-MS comparisons. Our analysts engage in direct comparisons of each new lot to prior in-house standards and internal synthetic controls. To preserve lot integrity during sampling and packaging, our standard operation calls for sub-sampling from homogenous bulk material, then careful sealing under controlled humidity and temperature. Every vial reflects a larger bulk that’s itself been surveyed in terms of uniform content, so results stay comparable, even if vials are used in different laboratories or at different times.
Reference standards don’t all serve the same need. We’ve seen countless analysts struggle with secondary standards that vary from lot to lot, or with commercial products that claim similar purity but offer little evidence of process background or scientific traceability. Unlike loosely specified or trader-sourced alternatives, our Fexofenadine Hydrochloride reference material brings analytical traceability directly tied to primary characterization. Laboratories can compare our certificate data with in-house results, not relying on hope or assumption, but on well-mapped quantitative values. This reduces the drift in calibrations and method validations that accumulates from weaker material sources.
Physical handling in analytical labs always introduces potential error. The more fragmented — or poorly unified — a standard’s supply chain, the greater the uncertainty in the actual quality of the standard in use. For Fexofenadine Hydrochloride, issues can emerge from improper drying, microcrystalline inconsistencies, or contamination through ambient moisture uptake. Our packaging workflow includes humidity-controlled handling, pre-weighed vialing, and inert atmosphere sealing for formats where long-term storage is anticipated. Because our process doesn’t reset for each order, we generate enough material per lot to support consistent results across multiple shipments and timelines. Experience shows that even small differences in crystalline habit or particle size can skew gravimetric or spectrometric measurements. By aligning our physical form with what analysts actually need — fine, free-flowing powder with precise water content — we help labs avoid guesswork.
Every reference standard batch leaves our facility with a certificate detailing not just a summary value, but a history of all characterization runs. Primary assay results, residual solvents, water content by Karl Fischer, and a spectrum of impurity profiles show our testing in practice. Each value ties back to our internal characterization process, so laboratories running method validations or compliance audit responses can inspect traceability in full context. In our years producing these materials, we’ve noted situations where labs have resolved regulatory challenges simply by supporting their work with a robust certificate from a trusted primary producer. Certificates alone won’t stop analytical drift, but built-in process rigor and data transparency make them powerful documentation.
Long-term stability for reference standards can make or break an analytical program. Unlike traders or resellers, we maintain stability samples for every batch in-house, stored under actual long-term and accelerated conditions. Real-time and forced degradation profiles are used to check assay integrity over months or years. Periodic re-testing of stored standards identifies any chemical transformation or physical degradation before it would impact users. This full-cycle approach extends beyond shelf life predictions to actual, measured data across production cycles. Many labs we have worked with rely on this level of manufacturer-maintained continuity so that they aren’t left wishing for stability data under deadline.
Our customers use Fexofenadine Hydrochloride as a quantitative anchor in HPLC, LC-MS, and capillary electrophoresis assays for both method development and regulatory submission. Through feedback from validation teams and regulatory affairs specialists, we have strengthened every step in our process to better suit what filings and audits really demand. True accuracy in quantitation or impurity profiling depends on starting from material with a trusted certificate. Internal tests comparing our reference material to compendial standards keep our specifications tuned so that users don't encounter unexpected analytical bias.
One advantage of working directly with laboratories comes from hearing how our standard performs under real-world conditions. Over time we have received reports ranging from confusion over minor impurity profiles to method drift in long-term study support. These have helped us broaden characterization, build out more robust certificate reporting, and sometimes adjust drying or sealing protocols. Feedback has led to tighter particulate and moisture controls, improvements in label transparency, and even batch-specific guidance for particular applications. This feedback loop benefits not just current, but all future users as lessons get implemented into each new lot.
Working as the manufacturer, we control the history and data for every lot made. Unlike products repackaged from third parties, or supplied through intermediaries who might lack original production documentation, our Fexofenadine Hydrochloride reference standard offers complete transparency from synthesis through to certificate reporting. There’s a clear distinction between creating standards purpose-built for quantitation and simply sourcing material from commercial sources. By holding in-house control over both synthetic process and analytical measurement, we reduce variability, avoid blind spots in impurity assessment, and maintain a direct chain of traceability.
Every lab faces frustration with standards that change appearance or lose potency during storage or repeated handling. Our deep process experience as manufacturers means we anticipate risks like static charge, caking, or desiccation drift. By selecting appropriate excipients for flow, setting package sizes to fit actual laboratory practice, and training our handling team in best laboratory techniques, we guard against common pitfalls that generic suppliers might miss. It’s not only about chemical purity; physical performance in day-to-day lab use matters equally.
Sustaining a standard requires constant vigilance — batch records, SOP adherence, and swift identification of even subtle shifts in analytical performance. Proprietary stability storage programs keep us apprised of lot evolution under stress or extended timeframes. Feedback-driven corrections get implemented swiftly, alongside transparent reporting for all aspect of production. Routine checks on retained samples further guarantee that what leaves our facility matches our initial purity, stability, and moisture signature.
Our materials have been cited in regulatory filings in markets with some of the world's strictest analytical requirements. Regular communication with customers facing regulatory audits or method disputes has strengthened the way we design documentation. Transparency in production, access to supporting analytical data, and readiness to provide clarification on impurity profiles or out-of-spec results help laboratories meet compliance without scrambling for third-party validation.
The landscape of pharmaceutical analytics never stays the same. Each laboratory’s experience informs how future reference materials get made. For decades, updates in instrument sensitivity, solvent compatibility, or regulatory requirements have prompted us to review and adapt both our production and characterization protocols. Sometimes changing a packaging configuration or shifting an analytical screening method makes a sizable difference for those developing new detection limits or resolving previously unseen interference patterns. In every case, the commitment runs deeper than surface claims: ongoing improvement based on live user data sets a manufactured standard apart from lower-tier alternatives.
Shipping reference materials worldwide isn’t as simple as labeling and dispatching. Fexofenadine Hydrochloride is susceptible to changes if exposed to excess heat, moisture, or airborne contamination. As producers, our risk mitigation includes controlled-environment packaging, gel desiccants, tamper-proof labeling, and options for specialized cold-chain shipment when needed by customer geography or research requirements. Refusals to cut corners in packaging materials and shipment methodology have paid dividends in minimizing real-world loss incidents and analytical drift observed by users.
Chemical manufacturing experience brings more than routine. Seasoned operators spot shifts early — a faint color change, a slight moisture pickup, a deviation in LC-MS fingerprint. With training that spans both chemical synthesis and analytical performance, our team assures that every vial can serve as a trusted benchmark for pharmaceutical research or final product release. As demands on analytical precision tighten, continual improvement and rigorous validation procedures turn each batch into both a scientific asset and a regulatory anchor.
By consistently providing high-purity, fully characterized Fexofenadine Hydrochloride reference standards, we aim to support pharmaceutical innovation and patient safety. Tracing each step from synthesis to certificate, sustaining robust documentation, and adapting to the evolving needs of analytical laboratories, we stand as a direct partner to those pushing boundaries in pharmaceutical quality control and safety evaluation. This work isn’t driven by marketing or speculation, but by decades of feedback, troubleshooting, and documented performance — the kind that only a direct manufacturer can promise and demonstrate.